The bimonthly Global Antibiotic Resistance Partnership (GARP) Newsletter, GARPNet News, covers work being done around the world by the Global Antibiotic Resistance Partnership; sign up to receive...
The Global Antibiotic Resistance Partnership (GARP) was started in 2009 to create a platform for developing actionable policy proposals on antibiotic resistance in low-income and middle-income countries.
During the first three years, Phase 1 of GARP established national working groups in four countries: India, Kenya, South Africa and Vietnam. Those working groups multidisciplinary, with representatives from all sectors, dealing with both human and animal antibiotic use have become national resources for their expertise and linkages to the current global activities in antibiotic resistance.
GARP Phase 1 culminated in the 1st Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance on October 3-5, 2011, in New Delhi, India. Since GARP Phase 2 began in 2012, national working groups have been established in Mozambique, Nepal, Tanzania and Uganda.
The GARP secretariat at the Center for Disease Dynamics, Economics & Policy (CDDEP), in Washington, DC and New Delhi, provides technical support to each working group, creates links within the GARP network and involves the working groups in global discussions and policy development.
GARP is a CDDEP project, funded by the Bill & Melinda Gates Foundation.
O grupo tinha como objectivos:
1. Avaliar o ponto de situação sobre o
- 1 of 11
- next ›
In his preface to the GARP-Tanzania Situation Analysis and Recommendations on Antibiotic Resistance in Tanzania, Professor Said Aboud, Chairman of the GARP-Tanzania Working...
- 1 of 14
- next ›